OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 58 filers reported holding OLEMA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,313,547 | +108.3% | 349,275 | +52.3% | 0.00% | 0.0% |
| Q2 2023 | $2,071,167 | -64.4% | 229,365 | +8.7% | 0.00% | -50.0% |
| Q3 2021 | $5,823,000 | -60.1% | 210,926 | -59.6% | 0.00% | -60.0% |
| Q2 2021 | $14,606,000 | -5.3% | 522,074 | +12.3% | 0.01% | 0.0% |
| Q1 2021 | $15,430,000 | -12.5% | 465,014 | +26.8% | 0.01% | -16.7% |
| Q4 2020 | $17,630,000 | – | 366,602 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $15,238,000 | 2.80% |
| Fairmount Funds Management LLC | 2,669,300 | $10,864,000 | 2.49% |
| BVF INC/IL | 7,611,503 | $30,979,000 | 1.50% |
| Vivo Capital, LLC | 1,689,515 | $6,876,000 | 0.69% |
| Cormorant Asset Management, LP | 2,082,000 | $8,474,000 | 0.64% |
| Newtyn Management, LLC | 500,000 | $2,035,000 | 0.39% |
| Kynam Capital Management, LP | 249,229 | $1,014,000 | 0.26% |
| Monaco Asset Management SAM | 130,000 | $529,000 | 0.23% |
| TANG CAPITAL MANAGEMENT LLC | 318,926 | $1,298,000 | 0.20% |
| Artal Group S.A. | 260,500 | $1,060,000 | 0.06% |